PTGX vs TPR · rev $269.8M vs P/E 46, rev $8.00B
Protagonist Therapeutics Inc (PTGX) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
PTGX currently screens at market cap $7.25B. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the PTGX and TPR stock pages for the full models.
Not investment advice.